OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The future of new drugs for diabetes management
Clifford J. Bailey, Caroline Day
Diabetes Research and Clinical Practice (2019) Vol. 155, pp. 107785-107785
Open Access | Times Cited: 44
Clifford J. Bailey, Caroline Day
Diabetes Research and Clinical Practice (2019) Vol. 155, pp. 107785-107785
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
Clifford J. Bailey, Caroline Day, Srikanth Bellary
Current Diabetes Reports (2022) Vol. 22, Iss. 1, pp. 39-52
Open Access | Times Cited: 140
Clifford J. Bailey, Caroline Day, Srikanth Bellary
Current Diabetes Reports (2022) Vol. 22, Iss. 1, pp. 39-52
Open Access | Times Cited: 140
Metformin: Therapeutic profile in the treatment of type 2 diabetes
Clifford J. Bailey
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S3, pp. 3-19
Open Access | Times Cited: 16
Clifford J. Bailey
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S3, pp. 3-19
Open Access | Times Cited: 16
Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future
Brian Godman, Debashis Basu, Yogan Pillay, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 113
Brian Godman, Debashis Basu, Yogan Pillay, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 113
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
Annamaria Mascolo, Raffaella Di Napoli, Nunzia Balzano, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 53
Annamaria Mascolo, Raffaella Di Napoli, Nunzia Balzano, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 53
Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure
Guntram Schernthaner, K. Brand, Clifford J. Bailey
Metabolism (2022) Vol. 130, pp. 155160-155160
Open Access | Times Cited: 42
Guntram Schernthaner, K. Brand, Clifford J. Bailey
Metabolism (2022) Vol. 130, pp. 155160-155160
Open Access | Times Cited: 42
Cost-of-illness study among patients with diabetes mellitus and coping mechanisms in Northern Ghana
Andrew Mpagwuni Ziblim, John Azaare, Robert Bagngmen Bio, et al.
BMJ Public Health (2025) Vol. 3, Iss. 1, pp. e001223-e001223
Open Access | Times Cited: 1
Andrew Mpagwuni Ziblim, John Azaare, Robert Bagngmen Bio, et al.
BMJ Public Health (2025) Vol. 3, Iss. 1, pp. e001223-e001223
Open Access | Times Cited: 1
Comparison of the efficacy and safety of GLP ‐1 receptor agonists on cardiovascular events and risk factors: A review and network meta‐analysis
Xuedong An, WenJie Sun, Zhige Wen, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access | Times Cited: 1
Xuedong An, WenJie Sun, Zhige Wen, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access | Times Cited: 1
The Use of GLP1R Agonists for the Treatment of Type 2 Diabetes in Kidney Transplant Recipients
Aleksandra Kukla, Jennifer M. Hill, Massini Merzkani, et al.
Transplantation Direct (2020) Vol. 6, Iss. 2, pp. e524-e524
Open Access | Times Cited: 56
Aleksandra Kukla, Jennifer M. Hill, Massini Merzkani, et al.
Transplantation Direct (2020) Vol. 6, Iss. 2, pp. e524-e524
Open Access | Times Cited: 56
SGLT2 inhibitors: a narrative review of efficacy and safety
Donald S. Nelinson, José Manuel Sosa, Robert Ćhilton
Journal of Osteopathic Medicine (2021) Vol. 121, Iss. 2, pp. 229-239
Open Access | Times Cited: 41
Donald S. Nelinson, José Manuel Sosa, Robert Ćhilton
Journal of Osteopathic Medicine (2021) Vol. 121, Iss. 2, pp. 229-239
Open Access | Times Cited: 41
Current status of GPR40/FFAR1 modulators in medicinal chemistry (2016–2019): a patent review
Zheng Li, Zongtao Zhou, Luyong Zhang
Expert Opinion on Therapeutic Patents (2019) Vol. 30, Iss. 1, pp. 27-38
Closed Access | Times Cited: 52
Zheng Li, Zongtao Zhou, Luyong Zhang
Expert Opinion on Therapeutic Patents (2019) Vol. 30, Iss. 1, pp. 27-38
Closed Access | Times Cited: 52
An update on current type 2 diabetes mellitus (T2DM) druggable targets and drugs targeting them
Prerna Uniyal, Surbhi Panwar, Anuj M. Bhatt, et al.
Molecular Diversity (2025)
Closed Access
Prerna Uniyal, Surbhi Panwar, Anuj M. Bhatt, et al.
Molecular Diversity (2025)
Closed Access
<p>Guava Leaf Extract Attenuates Insulin Resistance via the PI3K/Akt Signaling Pathway in a Type 2 Diabetic Mouse Model</p>
Qiong Yang, Yumei Wen, Jing Shen, et al.
Diabetes Metabolic Syndrome and Obesity (2020) Vol. Volume 13, pp. 713-718
Open Access | Times Cited: 22
Qiong Yang, Yumei Wen, Jing Shen, et al.
Diabetes Metabolic Syndrome and Obesity (2020) Vol. Volume 13, pp. 713-718
Open Access | Times Cited: 22
Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 as Potential Drugs for Type 2 Diabetes Mellitus—A Systematic Review of Clinical and In Vivo Preclinical Studies
Cristiana Almeida, Cristina Monteiro, Samuel Silvestre
Scientia Pharmaceutica (2021) Vol. 89, Iss. 1, pp. 5-5
Open Access | Times Cited: 19
Cristiana Almeida, Cristina Monteiro, Samuel Silvestre
Scientia Pharmaceutica (2021) Vol. 89, Iss. 1, pp. 5-5
Open Access | Times Cited: 19
Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panel
Agostino Consoli, Leszek Czupryniak, Rui Duarte, et al.
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. 10, pp. 1705-1713
Open Access | Times Cited: 20
Agostino Consoli, Leszek Czupryniak, Rui Duarte, et al.
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. 10, pp. 1705-1713
Open Access | Times Cited: 20
Exploring bulky natural and natural-like periphery in the design of p-(benzyloxy)phenylpropionic acid agonists of free fatty acid receptor 1 (GPR40)
Sergey O. Kuranov, Olga A. Luzina, Oleksandra Onopchenko, et al.
Bioorganic Chemistry (2020) Vol. 99, pp. 103830-103830
Closed Access | Times Cited: 17
Sergey O. Kuranov, Olga A. Luzina, Oleksandra Onopchenko, et al.
Bioorganic Chemistry (2020) Vol. 99, pp. 103830-103830
Closed Access | Times Cited: 17
Conservation of glucagon like peptide-1 level with liraglutide and linagilptin protects the kidney against angiotensin II-induced tissue fibrosis in rats
Feng Bai, Lihui Zhang, Weiwei Zhang, et al.
European Journal of Pharmacology (2019) Vol. 867, pp. 172844-172844
Closed Access | Times Cited: 16
Feng Bai, Lihui Zhang, Weiwei Zhang, et al.
European Journal of Pharmacology (2019) Vol. 867, pp. 172844-172844
Closed Access | Times Cited: 16
Role of GLP-1 Receptor Agonist in Diabetic Cardio-renal Disorder: Recent Updates of Clinical and Pre-clinical Evidence
Sanket Seksaria, Bhaskar Jyoti Dutta, Mandeep Kaur, et al.
Current Diabetes Reviews (2023) Vol. 20, Iss. 6
Closed Access | Times Cited: 5
Sanket Seksaria, Bhaskar Jyoti Dutta, Mandeep Kaur, et al.
Current Diabetes Reviews (2023) Vol. 20, Iss. 6
Closed Access | Times Cited: 5
Characterization of an Agarophyton chilense Oleoresin Containing PPARγ Natural Ligands with Insulin-Sensitizing Effects in a C57Bl/6J Mouse Model of Diet-Induced Obesity and Antioxidant Activity in Caenorhabditis elegans
Claudio Pinto, María Raquel Ibáñez, Gloria Loyola, et al.
Nutrients (2021) Vol. 13, Iss. 6, pp. 1828-1828
Open Access | Times Cited: 11
Claudio Pinto, María Raquel Ibáñez, Gloria Loyola, et al.
Nutrients (2021) Vol. 13, Iss. 6, pp. 1828-1828
Open Access | Times Cited: 11
Future Drug Treatments for Type 2 Diabetes
Clifford J. Bailey
(2024), pp. 1154-1166
Closed Access | Times Cited: 1
Clifford J. Bailey
(2024), pp. 1154-1166
Closed Access | Times Cited: 1
Oral Glucose‐Lowering Agents
Clifford J. Bailey, Andrew J. Krentz
(2024), pp. 492-519
Closed Access | Times Cited: 1
Clifford J. Bailey, Andrew J. Krentz
(2024), pp. 492-519
Closed Access | Times Cited: 1
Natural Products as Nano-Antidiabetic Drugs
Thottukara Madathil Archana, S. Sudheesh
(2024), pp. 531-552
Closed Access | Times Cited: 1
Thottukara Madathil Archana, S. Sudheesh
(2024), pp. 531-552
Closed Access | Times Cited: 1
Gastrointestinal safety evaluation of semaglutide for the treatment of type 2 diabetes mellitus: A meta-analysis
X. Huang, Miaohui Wu, Jiaojiao Lin, et al.
Medicine (2024) Vol. 103, Iss. 21, pp. e38236-e38236
Open Access | Times Cited: 1
X. Huang, Miaohui Wu, Jiaojiao Lin, et al.
Medicine (2024) Vol. 103, Iss. 21, pp. e38236-e38236
Open Access | Times Cited: 1
Understanding the Impact of Diabetes on Bone Health: A Clinical Review
Preeti Sharma, Rahul Sharma, Khushboo Gaur
Metabolism Open (2024) Vol. 24, pp. 100330-100330
Open Access | Times Cited: 1
Preeti Sharma, Rahul Sharma, Khushboo Gaur
Metabolism Open (2024) Vol. 24, pp. 100330-100330
Open Access | Times Cited: 1
Neural tone and cardio-renal outcomes in patients with type 2 diabetes mellitus: a review of the literature with a focus on SGLT2 inhibitors
Mouhamed Nashawi, Omar Sheikh, Ayman Battisha, et al.
Heart Failure Reviews (2020) Vol. 26, Iss. 3, pp. 643-652
Closed Access | Times Cited: 11
Mouhamed Nashawi, Omar Sheikh, Ayman Battisha, et al.
Heart Failure Reviews (2020) Vol. 26, Iss. 3, pp. 643-652
Closed Access | Times Cited: 11
Effects of artemether on pancreatic islet morphology, islet cell turnover and α-cell transdifferentiation in insulin-deficient Glu CreERT2;ROSA26-eYFP diabetic mice
Dipak Sarnobat, Ryan A. Lafferty, R. Charlotte Moffett, et al.
Journal of Pharmacy and Pharmacology (2022) Vol. 74, Iss. 12, pp. 1758-1764
Open Access | Times Cited: 6
Dipak Sarnobat, Ryan A. Lafferty, R. Charlotte Moffett, et al.
Journal of Pharmacy and Pharmacology (2022) Vol. 74, Iss. 12, pp. 1758-1764
Open Access | Times Cited: 6
